QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.066845v1 310/2/633    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maksymowych, A. B. Articles by Simpson, L. L. Search for Related Content PubMed PubMed Citation Articles by Maksymowych, A. B. Articles by Simpson, L. L.

TOXICOLOGY

Structural Features of the Botulinum Neurotoxin Molecule That Govern Binding and Transcytosis across Polarized Human Intestinal Epithelial Cells

Departments of Medicine (A.B.M., L.L.S.) and Biochemistry and Molecular Pharmacology (L.L.S.), Jefferson Medical College, Philadelphia, Pennsylvania

Experiments were done to help localize the minimum essential domain within the botulinum toxin molecule that is necessary for binding and transport across human gut epithelial cells. The data demonstrated that the neurotoxin alone, in the absence of auxiliary proteins, undergoes transcytosis. The neurotoxin by itself was examined in the single chain (unnicked serotype B) and dichain (nicked serotype B, nicked serotype A) forms, and all displayed the ability to bind and penetrate epithelial barriers. In addition, the single chain and dichain molecules were examined in the oxidized and reduced states, and again all forms were transported. To further define the minimum essential domain, experiments were done with two toxin fragments: 1) the heavy chain, which was derived from native toxin, and 2) the carboxy-terminal portion of the heavy chain, which was generated by recombinant techniques. Interestingly, both fragments were fully competent in crossing epithelial barriers. These data suggest that a polypeptide derived from the toxin could be used as a carrier domain to transport other molecules across epithelial cells. In related experiments, physiological (i.e., potassium depletion) and pharmacological (i.e., chlorpromazine) manipulations were used to implicate clathrin-coated pits/vesicles as the structures responsible for endocytosis of toxin.

Address correspondence to: Dr. Lance L. Simpson, Room 314-JAH, Jefferson Medical College, 1020 Locust St., Philadelphia, PA 19107. E-mail: lance.simpson{at}jefferson.edu

This article has been cited by other articles:

				F. H. Al-Saleem, D. M. Ancharski, E. Ravichandran, S. G. Joshi, A. K. Singh, Y. Gong, and L. L. Simpson The Role of Systemic Handling in the Pathophysiologic Actions of Botulinum Toxin J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 856 - 863. [Abstract] [Full Text] [PDF]

				E. Ravichandran, F. H. Al-Saleem, D. M. Ancharski, M. D. Elias, A. K. Singh, M. Shamim, Y. Gong, and L. L. Simpson Trivalent Vaccine against Botulinum Toxin Serotypes A, B, and E That Can Be Administered by the Mucosal Route Infect. Immun., June 1, 2007; 75(6): 3043 - 3054. [Abstract] [Full Text] [PDF]